Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Friederike Knipping
Observed name:
F. Knipping
Observed institutions:
University of Minnesota,
Inserm,
Institut Pasteur,
German Cancer Research Center,
National Center for Tumor Diseases
ORCID:
0000-0003-0071-2895
Observed ORCID:
0000-0003-0071-2895
OpenAlex ID:
A5084162538
Enhanced prime editing systems by manipulating cellular determinants of editing outcomes
2021
·
Peter J. Chen
, Jeffrey A. Hussmann
, et al.
·
Cell
·
818
Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases
2015
·
Mark J Osborn
, Beau R Webber
, et al.
·
Molecular Therapy
·
200
PDF
Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs
2019
·
Mark J. Osborn
, Gregory A. Newby
, et al.
·
Journal of Investigative Dermatology
·
94
Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing
2021
·
Friederike Knipping
, Gregory A. Newby
, et al.
·
Molecular Therapy
·
51
CRISPR/Cas9-Based Lateral Flow and Fluorescence Diagnostics
2021
·
Mark J. Osborn
, Akshay Bhardwaj
, et al.
·
Bioengineering
·
46
PDF
Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification
2017
·
Friederike Knipping
, Mark J. Osborn
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
39
PDF
Induction of anti-Tat neutralizing antibodies by the CyaA vector targeting dendritic cells: Influence of the insertion site and of the delivery of multicopies of the dominant Tat B-cell epitope
2010
·
Catherine Fayolle
, Maryline Davi
, et al.
·
Vaccine
·
7
Abstract 4867: Enhancing TCR-T with a Fas-based switch receptor boosts T cell engraftment, persistence, and anti-tumor activity in models of hard-to-treat PRAME solid tumor indications
2025
·
Laure Twyffels
, Alvaro Haroun-Izquierdo
, et al.
·
Cancer Research
375 Enhanced anti-tumor activity and T-cell fitness of 2nd-generation MAGE-A1 TCR T-cells incorporating distinct CD8 co-receptor designs
2023
·
Paul Najm
, Josephine Kemna
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
368 Counteracting TCR-T cell dysfunction in solid tumors through combination of FAS-based switch receptors and CD8-coreceptor
2023
·
Friederike Knipping
, Paul Najm
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
394 High-affinity PRAME TCRs synergize with tailored CD8 co-receptor and switch receptors to generate potential best-in-class PRAME-targeting TCR-T therapy
2023
·
Lia Walcher
, Lorenz Knackstedt
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
374 CRISPR/Cas9-base editing mediated correction for recessive dystrophic epidermolysis bullosa
2019
·
M. Osborn
, G. Newby
, et al.
·
Journal of Investigative Dermatology
PDF
Synergizing genome editing and cancer immunotherapy
2017
·
Richard Gabriel
, Friederike Knipping
, et al.
·
Translational Cancer Research
121. T Cell Receptor Modification by Highly Specific TALEN and CRISPR/Cas9
2016
·
Friederike Knipping
, Karl Petri
, et al.
·
Molecular Therapy
PDF
Megatal, Crispr/Cas9, and Talen T-Cell Receptor Gene Editing
2015
·
Mark J. Osborn
, Beau R Webber
, et al.
·
Blood
562. Modification of TCR Specificity by TALEN and CRISPR
2015
·
Friederike Knipping
, Karl Petri
, et al.
·
Molecular Therapy
PDF
Show more works
View as search
Works count:
16
Citation count:
1,255
H-index:
7
I10-index:
6
Year
Topic
Type